Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes
Abstract Introduction This randomized, prospective study (MATCH) was designed to assess the clinical utility of a machine learning-based tool (Mind.Px) that predicts patient response to the biologic drug classes used in the management of psoriasis. Methods Patients with psoriasis who were biologic n...
Saved in:
| Main Authors: | Bruce E. Strober, Michael Bukhalo, April W. Armstrong, David Pariser, Leon Kircik, Brian Johnson, Paul Montgomery, Tobin J. Dickerson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-05-01
|
| Series: | Dermatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s13555-025-01441-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International Psoriasis Council Classification
by: Bruce Strober, et al.
Published: (2025-07-01) -
Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry
by: Bruce Strober, et al.
Published: (2024-12-01) -
Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States
by: April Armstrong, et al.
Published: (2024-12-01) -
Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan
by: Celine Miyazaki, et al.
Published: (2024-12-01) -
Serious generalized pustular psoriasis with evolution to plaque psoriasis: approach with spesolimab
by: Liz S. Gea, et al.
Published: (2024-10-01)